UK markets open in 3 hours 14 minutes

Cross Country Healthcare, Inc. (CCRN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
17.40-0.17 (-0.97%)
At close: 04:00PM EDT
17.40 0.00 (0.00%)
After hours: 04:20PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 603.39M
Enterprise value 591.56M
Trailing P/E 8.49
Forward P/E 18.32
PEG ratio (5-yr expected) 1.83
Price/sales (ttm)0.31
Price/book (mrq)1.27
Enterprise value/revenue 0.29
Enterprise value/EBITDA 4.57

Trading information

Stock price history

Beta (5Y monthly) 0.75
52-week change 3-20.84%
S&P500 52-week change 321.08%
52-week high 328.75
52-week low 315.65
50-day moving average 318.03
200-day moving average 321.70

Share statistics

Avg vol (3-month) 3498.53k
Avg vol (10-day) 3256.09k
Shares outstanding 534.68M
Implied shares outstanding 635.02M
Float 832.63M
% held by insiders 15.17%
% held by institutions 1110.90%
Shares short (15 Apr 2024) 45.11M
Short ratio (15 Apr 2024) 414.41
Short % of float (15 Apr 2024) 418.95%
Short % of shares outstanding (15 Apr 2024) 414.73%
Shares short (prior month 15 Mar 2024) 45.27M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Dec 2023

Profitability

Profit margin 3.60%
Operating margin (ttm)3.45%

Management effectiveness

Return on assets (ttm)9.00%
Return on equity (ttm)15.61%

Income statement

Revenue (ttm)2.02B
Revenue per share (ttm)57.45
Quarterly revenue growth (yoy)-34.10%
Gross profit (ttm)N/A
EBITDA 134.96M
Net income avi to common (ttm)72.63M
Diluted EPS (ttm)2.05
Quarterly earnings growth (yoy)-76.70%

Balance sheet

Total cash (mrq)17.09M
Total cash per share (mrq)0.49
Total debt (mrq)5.27M
Total debt/equity (mrq)1.11%
Current ratio (mrq)2.79
Book value per share (mrq)13.77

Cash flow statement

Operating cash flow (ttm)248.5M
Levered free cash flow (ttm)231.57M